SEC Form 4 · accession 0001144204-16-076053
TITAN PHARMACEUTICALS INC · TTNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sunil Bhonsle
Officer — President and CEO · Director
Period of report
Jan 15, 2016
Accepted (ET)
Jan 19, 2016 · 4:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000910267
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 15, 2016 | P | 5,841 | $2.72 | A | 113,815 | D | |
| Common StockF1 | holding | — | — | — | 54,684 | I | By Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person serves as trustee of the family trust.